Houang, Evelyne M.
Sham, Yuk Y.
Bates, Frank S.
Metzger, Joseph M.
Funding for this research was provided by:
National Institutes of Health (AR071349, HL122323)
Muscular Dystrophy Association
Article History
Received: 30 May 2018
Accepted: 13 September 2018
First Online: 10 October 2018
Ethics approval and consent to participate
: Not applicable
: Not applicable
: The authors declare the following potential conflict of interest: J.M.M. is on the scientific advisory board of and holds zero value equity shares in Phrixus Pharmaceuticals Inc., a company developing novel therapeutics for heart failure and DMD, and this is actively managed by the UMN Office of Institutional Compliance.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.